3 Result(s)

Article

AMPD1: a novel therapeutic target for reversing insulin resistance

Insulin resistance is one of the hallmark manifestations of obesity and Type II diabetes and reversal of this pathogenic abnormality is an attractive target for new therapies for Type II diabetes. A recent rep...

Jidong Cheng, Hiroko Morisaki, Keiko Toyama, Naomi Sugimoto… in BMC Endocrine Disorders (2014)

Article

AMPD1 regulates mTORC1-p70 S6 kinase axis in the control of insulin sensitivity in skeletal muscle

Insulin resistance triggered by excess fat is a key pathogenic factor that promotes type 2 diabetes. Understanding molecular mechanisms of insulin resistance may lead to the identification of a novel therapeut...

Andreas AK Tandelilin, Tetsuaki Hirase, Athanasius W Hudoyo… in BMC Endocrine Disorders (2015)

Article

Erratum to: AMPD1 regulates mTORC1-p70 S6 kinase axis in the control of insulin sensitivity in skeletal muscle

Andreas A. K. Tandelilin, Tetsuaki Hirase, Athanasius W. Hudoyo… in BMC Endocrine Disorders (2015)